249 related articles for article (PubMed ID: 36563921)
41. Protocol for a mobile laboratory study of co-administration of cannabis concentrates with a standard alcohol dose in humans.
Karoly HC; Prince MA; Emery NN; Smith EE; Piercey CJ; Conner BT
PLoS One; 2022; 17(11):e0277123. PubMed ID: 36327298
[TBL] [Abstract][Full Text] [Related]
42. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination.
Robaina Cabrera CL; Keir-Rudman S; Horniman N; Clarkson N; Page C
Pulm Pharmacol Ther; 2021 Aug; 69():102047. PubMed ID: 34082108
[TBL] [Abstract][Full Text] [Related]
43. Source of cannabinoids: what is available, what is used, and where does it come from?
Specchio N; Pietrafusa N; Cross HJ
Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
[TBL] [Abstract][Full Text] [Related]
44. Applications of Capillary Electrophoresis for the Determination of Cannabinoids in Different Matrices.
Blebea NM; Hancu G; Vlad RA; Pricopie A
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677696
[TBL] [Abstract][Full Text] [Related]
45. Pharmacology of cannabinoids in the treatment of epilepsy.
Gaston TE; Friedman D
Epilepsy Behav; 2017 May; 70(Pt B):313-318. PubMed ID: 28087250
[TBL] [Abstract][Full Text] [Related]
46. Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations.
Moore CF; Weerts EM
Psychopharmacology (Berl); 2022 May; 239(5):1397-1408. PubMed ID: 34652500
[TBL] [Abstract][Full Text] [Related]
47. Receptor-mediated effects of Δ
Preteroti MW; Traboulsi H; Greiss P; Lapohos O; Fonseca GJ; Eidelman DH; Baglole CJ
Immunol Cell Biol; 2023 Feb; 101(2):156-170. PubMed ID: 36510483
[TBL] [Abstract][Full Text] [Related]
48. Antinociceptive effects of minor cannabinoids, terpenes and flavonoids in Cannabis.
Rodriguez CEB; Ouyang L; Kandasamy R
Behav Pharmacol; 2022 Apr; 33(2&3):130-157. PubMed ID: 33709984
[TBL] [Abstract][Full Text] [Related]
49. Terpenes and Cannabinoids Yields and Profile from Direct-Seeded and Transplanted CBD-
Zheljazkov VD; Noller JS; Maggi F; Dale R
J Agric Food Chem; 2022 Aug; 70(34):10417-10428. PubMed ID: 35436102
[TBL] [Abstract][Full Text] [Related]
50. Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis.
Freeman TP; Craft S; Wilson J; Stylianou S; ElSohly M; Di Forti M; Lynskey MT
Addiction; 2021 May; 116(5):1000-1010. PubMed ID: 33160291
[TBL] [Abstract][Full Text] [Related]
51. Neuromolecular Mechanisms of Cannabis Action.
Adel Y; Alexander SPH
Adv Exp Med Biol; 2021; 1264():15-28. PubMed ID: 33332001
[TBL] [Abstract][Full Text] [Related]
52. Mechanisms of Action and Pharmacokinetics of Cannabis.
Chayasirisobhon S
Perm J; 2020 Dec; 25():1-3. PubMed ID: 33635755
[TBL] [Abstract][Full Text] [Related]
53. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
Bhattacharyya S; Morrison PD; Fusar-Poli P; Martin-Santos R; Borgwardt S; Winton-Brown T; Nosarti C; O' Carroll CM; Seal M; Allen P; Mehta MA; Stone JM; Tunstall N; Giampietro V; Kapur S; Murray RM; Zuardi AW; Crippa JA; Atakan Z; McGuire PK
Neuropsychopharmacology; 2010 Feb; 35(3):764-74. PubMed ID: 19924114
[TBL] [Abstract][Full Text] [Related]
54. Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis.
Todd SM; Arnold JC
Br J Pharmacol; 2016 Jan; 173(1):53-65. PubMed ID: 26377899
[TBL] [Abstract][Full Text] [Related]
55. Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users.
Weinstein A; Livny A; Weizman A
Curr Pharm Des; 2016; 22(42):6366-6379. PubMed ID: 27549374
[TBL] [Abstract][Full Text] [Related]
56. Associations between regular cannabis use and brain resting-state functional connectivity in adolescents and adults.
Ertl N; Lawn W; Mokrysz C; Freeman TP; Alnagger N; Borissova A; Fernandez-Vinson N; Lees R; Ofori S; Petrilli K; Trinci K; Viding E; Curran HV; Wall MB
J Psychopharmacol; 2023 Sep; 37(9):904-919. PubMed ID: 37515469
[TBL] [Abstract][Full Text] [Related]
57. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
[TBL] [Abstract][Full Text] [Related]
58. A Critical Review of the Role of the Cannabinoid Compounds Δ
Jones É; Vlachou S
Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
[TBL] [Abstract][Full Text] [Related]
59. Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice.
Iannotti FA; Pagano E; Moriello AS; Alvino FG; Sorrentino NC; D'Orsi L; Gazzerro E; Capasso R; De Leonibus E; De Petrocellis L; Di Marzo V
Br J Pharmacol; 2019 May; 176(10):1568-1584. PubMed ID: 30074247
[TBL] [Abstract][Full Text] [Related]
60. Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores.
Spindle TR; Sholler DJ; Cone EJ; Murphy TP; ElSohly M; Winecker RE; Flegel RR; Bonn-Miller MO; Vandrey R
JAMA Netw Open; 2022 Jul; 5(7):e2223019. PubMed ID: 35857320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]